• 1. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 2. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles Benzoxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles

Professional Introduction to 5-(Tert-Butyl)-2-methylbenzoxazole (CAS No. 40874-54-2)

5-(Tert-Butyl)-2-methylbenzoxazole, with the chemical formula C??H??O? and CAS number 40874-54-2, is a significant compound in the field of pharmaceutical and chemical research. This benzoxazole derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The presence of a tert-butyl group at the 5-position and a methyl group at the 2-position imparts distinct electronic and steric characteristics, making it a valuable scaffold for drug design.

The benzoxazole core is a well-studied heterocyclic system known for its biological activity. It is frequently incorporated into molecules targeting various therapeutic areas, including anticancer, anti-inflammatory, and antimicrobial applications. The tert-butyl substituent enhances lipophilicity and metabolic stability, while the methyl group influences electronic distribution, affecting interactions with biological targets. These features make 5-(Tert-Butyl)-2-methylbenzoxazole a promising candidate for further exploration.

In recent years, there has been growing interest in benzoxazole derivatives as pharmacophores. Studies have demonstrated that modifications at the 2- and 5-positions can significantly alter biological activity. For instance, research published in journals such as *Journal of Medicinal Chemistry* has highlighted the potential of 5-(Tert-Butyl)-2-methylbenzoxazole in inhibiting specific enzymes involved in cancer progression. The tert-butyl group’s steric bulk can prevent unwanted side interactions, while the methyl group’s electron-donating nature can modulate receptor binding affinity.

One notable study investigated the compound’s interaction with kinases, which are critical targets in oncology. The findings suggested that 5-(Tert-Butyl)-2-methylbenzoxazole exhibits inhibitory effects on certain kinase isoforms by occupying specific binding pockets. This mechanism aligns with current trends in kinase inhibition research, where structural optimization is key to improving selectivity and efficacy. The compound’s stability under physiological conditions further enhances its appeal as a lead molecule.

Additionally, the synthesis of 5-(Tert-Butyl)-2-methylbenzoxazole has been refined to achieve high yields and purity. Modern synthetic methodologies, including transition metal-catalyzed reactions and palladium-mediated cross-coupling, have enabled efficient construction of the benzoxazole ring system. These advancements have reduced production costs and improved scalability, making it more feasible for industrial applications.

The pharmaceutical industry has also explored derivatives of 5-(Tert-Butyl)-2-methylbenzoxazole for their potential in treating neurological disorders. Preliminary data indicate that certain analogs may modulate neurotransmitter release or receptor activity without significant off-target effects. This aligns with the broader goal of developing treatments for neurodegenerative diseases while minimizing adverse reactions.

From a chemical biology perspective, 5-(Tert-Butyl)-2-methylbenzoxazole serves as a useful tool for understanding molecular recognition processes. Its rigid benzoxazole core provides a stable framework for studying protein-ligand interactions, while the substituents allow fine-tuning of binding properties. Such studies contribute to our fundamental understanding of drug-receptor dynamics and inform future drug design strategies.

The compound’s versatility extends to material science applications as well. Researchers have explored its use in organic electronics due to its aromatic structure and electron-deficient nature. Potential applications include light-emitting diodes (LEDs) and organic photovoltaics (OPVs), where benzoxazole derivatives can enhance performance through their electronic characteristics.

In conclusion, 5-(Tert-Butyl)-2-methylbenzoxazole (CAS No. 40874-54-2) represents a multifaceted compound with significant potential across multiple domains of science and industry. Its unique structural features, combined with recent advancements in synthetic chemistry and biological evaluation, position it as a valuable asset for researchers seeking novel molecular scaffolds. As investigations continue to uncover new applications, this benzoxazole derivative is poised to play an increasingly important role in both academic research and industrial development.

• 64130-73-0(Benzoxazole, 5,7-bis(1,1-dimethylethyl)-2-methyl-)
• 29078-21-5(Benzoxazole,2-methyl-7-(1-methylethyl)-)
• 5676-58-4(2,5-Dimethylbenzoxazole)
• 53012-61-6(Benzoxazole,2,6-dimethyl-)
• 126892-00-0(Benzoxazole,2-methyl-5-(1-methylethyl)-)
• 92552-31-3(5-benzyl-2-methylbenzoxazole)
• 1119449-45-4((5-tert-butyl-1,3-benzoxazol-2-yl)methylamine hydrochloride)
• 139656-59-0(Benzoxazole, 7-(1,1-dimethylethyl)-2,5-dimethyl-)
• 50333-55-6(Benzoxazole, 2,2'-(1,4-phenylene)bis[5-(1,1-dimethylethyl)-)
• 1267427-47-3(5-(tert-Butyl)-2-ethylbenzoxazole)